Sanofi
SNY
572 hedge funds and large institutions have $9.77B invested in Sanofi in 2021 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 214 increasing their positions, 182 reducing their positions, and 79 closing their positions.
99% more call options, than puts
Call options by funds: $53.2M | Put options by funds: $26.7M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
18% more repeat investments, than reductions
Existing positions increased: 214 | Existing positions reduced: 182
15% more capital invested
Capital invested by funds: $8.52B → $9.77B (+$1.25B)
1.76% more ownership
Funds ownership: 13.9% → 15.66% (+1.8%)
5% less funds holding
Funds holding: 602 → 572 (-30)
30% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 79
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$1.4B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$66.1M |
| 3 |
BlackRock
New York
|
+$64.8M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$47.9M |
| 5 |
CCM
Cullen Capital Management
New York
|
+$42.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$205M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$96.4M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$67M |
| 4 |
Morgan Stanley
New York
|
-$61.5M |
| 5 |
CI
Cambiar Investors
Denver,
Colorado
|
-$50.1M |
SNY Hedge Fund Activity: Q1 2021 in Review
572 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2021, worth a combined $9.77B — up 15% from $8.52B a quarter earlier.
Sellers outnumbered buyers: 79 funds closed out of SNY and 55 opened new positions — a net loss of 24 holders — while 182 trimmed existing stakes and 214 added.
The largest buyer was Dodge & Cox, adding an estimated $1.4B. The largest seller was Fidelity Investments, cutting an estimated $205M.
- 572 institutional investors held Sanofi (SNY) as of Q1 2021, down from 602 in Q4 2020.
- Funds reported $9.77B of Sanofi stock for Q1 2021, up 15% quarter-over-quarter.
- 55 funds opened new Sanofi positions in Q1 2021 and 79 closed out, a net change of -24 holders.
- The largest Sanofi buyer in Q1 2021 was Dodge & Cox, an estimated $1.4B added.
- The largest Sanofi seller in Q1 2021 was Fidelity Investments, an estimated $205M sold.
Based on aggregated 13F filings for Q1 2021.